U.S. Markets open in 6 hrs 24 mins

Transcriptomics | World Market Analysis and Outlook 2019-2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--

The "Transcriptomics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Transcriptomics market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 13.9%.

Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.1 Billion by the year 2025, Microarray will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 15% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$243.9 Million to the region's size and clout in the next 5 to 6 years. Over US$286.5 Million worth of projected demand in the region will come from the rest of the European markets.

In Japan, Microarray will reach a market size of US$213.2 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.8% over the next couple of years and add approximately US$1.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.

All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:

  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina Inc.
  • MilliporeSigma
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/wo7vsk

View source version on businesswire.com: https://www.businesswire.com/news/home/20191129005341/en/